Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic and Pharmacodynamic Study of Ilera Medical Marijuana Products

NCT03886753 is registered in ClinicalTrials.gov with Children's Hospital of Philadelphia as lead sponsor.

NCT NCT03886753
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03886753 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic and Pharmacodynamic Study of Ilera Medical Marijuana Products
Lead sponsor
Children's Hospital of Philadelphia
Phase
Observational
Overall status
Terminated
Start date
May 15, 2019
Completion date
June 30, 2020
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

als, autism spectrum disorder, cancer, dyskinetic syndrome, epilepsy, glaucoma, hiv/aids, huntington disease, inflammatory bowel disease (ibd), intractable pain, multiple sclerosis, neuropathy, opioid use, parkinson disease, ptsd, sickle cell disease, spasticity, muscle, terminal illness